Chancery Lane CEO: Six trusts for an income-generating ISA
Investors can find steady streams of revenue outside of the mainstream dividend giants
Investors can find steady streams of revenue outside of the mainstream dividend giants
Exciting developments are underway in the healthcare world, and these three companies are leading that change
Mike Coop asks whether having exposure to the region is still worthwhile
Wealth managers need to integrate AI, but it must be in a pragmatic and grounded way, says Mallowstreet’s Stu Breyer
Chinese growth has slowed, but it is far from over, says Polar Capital’s Jerry Wu
High yield bonds had a strong 2023 but the cracks are starting to show, writes FundCalibre’s Darius McDermott
Pessimism is rife in the UK, but Man Group’s Henry Dixon and Jack Barrat say it is worth challenging that widely-held mindset
Nicholas Price argues that Japan equity valuations are still undemanding
The world is diverging, and Latin American may be able to take advantage
Record-high share buybacks have failed to stem widening discounts
2024 is likely to be another uphill battle for China, writes Janet Mui
Antidiabetic drugs such as Ozempic have markets excited about healthcare, but AllianceBernstein’s Vinay Thapar calls for caution amongst the hype